__timestamp | Takeda Pharmaceutical Company Limited | argenx SE |
---|---|---|
Wednesday, January 1, 2014 | 612613000000 | 4241601.57 |
Thursday, January 1, 2015 | 650773000000 | 5392385.38 |
Friday, January 1, 2016 | 619061000000 | 7370036.73 |
Sunday, January 1, 2017 | 628106000000 | 14970357 |
Monday, January 1, 2018 | 717599000000 | 31413266 |
Tuesday, January 1, 2019 | 964737000000 | 72279461 |
Wednesday, January 1, 2020 | 875663000000 | 183907682 |
Friday, January 1, 2021 | 886361000000 | 307644000 |
Saturday, January 1, 2022 | 997309000000 | 472132000 |
Sunday, January 1, 2023 | 1053819000000 | 709539000 |
Monday, January 1, 2024 | 1053819000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, operational costs play a pivotal role in shaping a company's financial health. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: Takeda Pharmaceutical Company Limited and argenx SE, from 2014 to 2023.
Takeda, a Japanese giant, has consistently demonstrated a robust financial strategy, with SG&A expenses peaking at approximately 1.05 trillion yen in 2023, marking a 72% increase from 2014. In contrast, argenx SE, a Belgian biotech firm, has shown a remarkable growth trajectory, with expenses surging by over 16,600% during the same period, albeit from a much smaller base.
This stark contrast highlights the diverse financial strategies and growth phases of these companies, offering valuable insights into their operational efficiencies and market positioning.
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Annual Comparison of SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline
5 Year Trend in Average Market Capitalization for AbbVie
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Number of Employees for Top 10 Healthcare Companies
Number of Employees for Top 10 Pharma Companies
Average Market Capitalization of Abbvie Annually
5 Year Trend in Market Capitalization for AbbVie
5 Year Trend in Average Market Capitalization for AbbVie
Comparison of Net Income Margin for Glaxosmithkline, AstraZeneca, Takeda, and Eli Lilly Over the Last 8 Quarters